Varespladib methyl
CAS No. 172733-08-3
Varespladib methyl( A-002 | LY333013 )
Catalog No. M26858 CAS No. 172733-08-3
Varespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 267 | In Stock |
|
| 10MG | 430 | In Stock |
|
| 25MG | 710 | In Stock |
|
| 50MG | 972 | In Stock |
|
| 100MG | 1332 | In Stock |
|
| 500MG | 2673 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVarespladib methyl
-
NoteResearch use only, not for human use.
-
Brief DescriptionVarespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor.
-
DescriptionVarespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor. (In Vitro):Varespladib methyl display high-level secretory PLA2 inhibition at nanomolar and picomolar concentrations against 28 medically important snake venoms from six continents .
-
In Vitro——
-
In Vivo——
-
SynonymsA-002 | LY333013
-
PathwayOthers
-
TargetOther Targets
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number172733-08-3
-
Formula Weight394.427
-
Molecular FormulaC22H22N2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (253.54 mM)
-
SMILESCCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Morley SR, Forrest AR, Galloway JH. Validation of meconin as a marker for illicit opiate use. J Anal Toxicol. 2007 Mar;31(2):105-8.
molnova catalog
related products
-
MRT-81
MRT-81 inhibits human and rodent smoothened?Smo?receptors effectively with an IC50?value of 41 nM in the Shh-light2 cells. MRT-81 has potent hedgehog inhibiting activity. MRT-81 also can be used for the research of cancer.
-
Nitrilotriacetic aci...
Nitrilotriacetic acid (Nitriloacetate) is a chelator that tracks and enriches His-tagged proteins in living cells by reacting with divalent metal ions-mediated 6His tagging.
-
Codrituzumab
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC).
Cart
sales@molnova.com